Risk of obstructive sleep apnea after treatment of head and neck squamous cell carcinoma: a cross-sectional study

被引:6
作者
Gavidia, Ronald [1 ]
Dunietz, Galit Levi [1 ]
O'Brien, Louise M. [1 ]
Schutz, Sonja G. [1 ]
Spector, Matthew E. [2 ]
Swiecicki, Paul L. [3 ]
Chervin, Ronald D. [1 ]
机构
[1] Univ Michigan, Dept Neurol, Div Sleep Med, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Otolaryngol & Head & Neck Surg, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Internal Med, Div Hematol & Oncol, Ann Arbor, MI 48109 USA
来源
JOURNAL OF CLINICAL SLEEP MEDICINE | 2022年 / 18卷 / 06期
基金
美国国家卫生研究院;
关键词
head and neck squamous cell carcinoma; obstructive sleep apnea; tumor location; tumor stage; cancer treatment; OROPHARYNGEAL CANCER; BERLIN QUESTIONNAIRE; QUALITY; EPIDEMIOLOGY; TONGUE; INDEX; STOP; HPV;
D O I
10.5664/jcsm.9954
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Study Objectives: Head and neck squamous cell carcinoma (HNSCC) or its treatment may be associated with an increased risk of obstructive sleep apnea (OSA). However, reported relationships between OSA risk factors and HNSCC are inconsistent. This study examined associations between tumor variables and risk of OSA at least 1 year after completion of treatment for HNSCC. Methods: This cross-sectional study included HNSCC patients of a large academic medical center. Inclusion criteria were age >= 18 years, cancer free for at least 1 year, and absence of tracheostomy or mental impairment. The STOP-BANG questionnaire, with a threshold >= 3, was used to classify HNSCC patients into elevated and low OSA risk. Tumor characteristics and treatment types were obtained from medical records. Descriptive statistics were used to compare characteristics between OSA risk groups. Unadjusted and age- adjusted logistic and linear regression models were used to explore associations between exposures and OSA risk. Results: Among 67 participants, 85% were males, mean age was 62.0 years ( 8.0 standard deviation), mean body mass index was 28.7 kg/m(2) ( 4.6 standard deviation), and mean neck circumference was 16.3 inches ( 1.2 standard deviation). Three-quarters of participants received chemoradiation only. Elevated OSA risk was observed in 60% of the participants. Tumor location, tumor stage, and type of cancer treatment were not different between OSA risk groups. Hyperlipidemia was more common in the elevated OSA risk group vs the low-risk group (n = 16, 40% vs n = 2, 7%, P =.004). Age-adjusted analysis showed a trend toward 2-fold increased odds of elevated OSA risk in patients with tumors at the base of the tongue in comparison to other locations (odds ratio = 2.3, 95% confidence interval 0.9, 6.4). No associations between tumor stage, cancer treatment, and elevated OSA risk were observed. Conclusions: Elevated OSA risk was common after HNSCC treatment. However, measured HNSCC characteristics generally were not different between elevated and low OSA risk groups. Given the high frequency of OSA that appears likely to exist in HNSCC patients, clinicians should inquire about OSA features in patients with a history of HNSCC.
引用
收藏
页码:1681 / 1686
页数:6
相关论文
共 39 条
  • [1] 2017, AJCC Cancer Staging Manual, P53
  • [2] Comparison of a sleep quality index between normal and obstructive sleep apnea patients
    Balakrishnan, Ganesh
    Burli, Divya
    Burk, John R.
    Lucas, Edgar A.
    Behbehani, Khosrow
    [J]. 2005 27TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7, 2005, : 1154 - 1157
  • [3] Brockstein B, OVERVIEW TREATMENT H
  • [4] Diagnostic accuracy of the Berlin questionnaire, STOP-BANG, STOP, and Epworth sleepiness scale in detecting obstructive sleep apnea: A bivariate meta-analysis
    Chiu, Hsiao-Yean
    Chen, Pin-Yuan
    Chuang, Li-Pang
    Chen, Ning-Hung
    Tu, Yu-Kang
    Hsieh, Yu-Jung
    Wang, Yu-Chi
    Guilleminault, Christian
    [J]. SLEEP MEDICINE REVIEWS, 2017, 36 : 57 - 70
  • [5] STOP questionnaire - A tool to screen patients for obstructive sleep apnea
    Chung, Frances
    Yegneswaran, Balaji
    Liao, Pu
    Chung, Sharon A.
    Vairavanathan, Santhira
    Islam, Sazzadul
    Khajehdehi, Ali
    Shapiro, Colin M.
    [J]. ANESTHESIOLOGY, 2008, 108 (05) : 812 - 821
  • [6] Dunietz G. L., 2021, Sleep, V44, pzsab076, DOI [10.1093/sleep/zsab076, DOI 10.1093/SLEEP/ZSAB076, https://doi.org/10.1093/sleep/zsab076]
  • [7] Elrefaey S, 2014, ACTA OTORHINOLARYNGO, V34, P299
  • [8] Foroughi Moein, 2017, Tanaffos, V16, P217
  • [9] Changes in the proportion of squamous cell carcinoma in head and neck cancer in the United States and Canada, 1995-2015.
    Gaubatz, Matthew
    Bukatko, Aleksandr R.
    Polednik, Katherine M.
    Simpson, Matthew C.
    Boakye, Eric Adjei
    Mohammed, Kahee A.
    Osazuwa-Peters, Nosayaba
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Obstructive sleep apnea in patients with head and neck cancer: a systematic review
    Gavidia, Ronald
    Dunietz, Galit Levi
    O'Brien, Louise
    Shannon, Carol
    Schuetz, Sonja
    Spector, Matthew
    Swiecicki, Paul
    Chervin, Ronald D.
    [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2021, 17 (05): : 1109 - 1116